CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

被引:51
作者
Tullberg, M [1 ]
Månsson, JE [1 ]
Fredman, P [1 ]
Lekman, A [1 ]
Blennow, K [1 ]
Ekman, R [1 ]
Rosengren, LE [1 ]
Tisell, M [1 ]
Wikkelso, C [1 ]
机构
[1] Univ Gothenburg, Sahlgrens Univ Hosp, Inst Clin Neurosci, SE-41345 Gothenburg, Sweden
关键词
normal pressure hydrocephalus; subcortical arteriosclerotic encephalopathy; sulfatide;
D O I
10.1136/jnnp.69.1.74
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-To examine the CSF concentrations of molecules reflecting demyelination, neuronal and axonal degeneration, gliosis, monoaminergic neuronal function, and aminergic and peptidergic neurotransmission in a large series of patients with normal pressure hydrocephalus (NPH) or subcortical arteriosclerotic encephalopathy (SAE), to elucidate pathogenic, diagnostic, and prognostic features. Methods-CSF concentrations of glycosphingolipid (sulfatide), proteins (neurofilament triplet protein (NFL), glial fibrillary acidic protein (GFAP)), neuropeptides (vasoactive intestinal peptide (VIP), 4-aminobutyric acid (GABA)), and monoamines (homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5-HIAA), 4-hydroxy-3-methoxyphenylglycol (HMPG)) were analysed in 43 patients with NPH and 19 patients with SAE. The diagnoses of NPH and SAE were based on strict criteria and patients with NPH were subsequently operated on. Twelve clinical variables, psychometric tests measuring perceptual speed, accuracy, learning, and memory and a psychiatric evaluation were performed in all patients and before and after a shunt operation in patients with NPH. Results-The CSF sulfatide concentration was markedly increased in patients with SAE (mean 766, range 300-3800 nmol/l) compared with patients with NPH (mean 206, range 50-400 nmol/l) (p<0.001). 5-HIAA, GABA, and VIP in CSF were higher in patients with SAE than in patients with NPH. The patients with NPH with cerebrovascular aetiology had higher sulfatide concentrations and a poorer outcome after shunt surgery than patients with NPH with other aetiologies. Conclusions-The pathogenesis of the white matter changes in NPH and SAE is different and ischaemic white matter changes can be a part of the NPH state. The markedly increased CSF sulfatide concentrations in patients with SAE indicate ongoing demyelination as an important pathophysiological feature of SAE. The CSF sulfatide concentration distinguished between patients with SAE and those with NPH with a sensitivity of 74% and a specificity of 94%, making it an important diagnostic marker.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 54 条
[11]   RELATION BETWEEN MRI FEATURES AND DEMENTIA IN CEREBROVASCULAR-DISEASE PATIENTS WITH LEUKOARAIOSIS - A LONGITUDINAL-STUDY [J].
BRACCO, L ;
CAMPANI, D ;
BARATTI, E ;
LIPPI, A ;
INZITARI, D ;
PRACUCCI, G ;
AMADUCCI, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 120 (02) :131-136
[12]  
Bradley J. V., 1968, Distribution-free statistical tests (Chapter 12)
[13]  
BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31
[14]   PATHOLOGY AND PATHOPHYSIOLOGY OF CEREBROVASCULAR DEMENTIA - PURE SUBGROUPS OF OBSTRUCTIVE AND HYPOPERFUSIVE ETIOLOGY [J].
BRUN, A .
DEMENTIA, 1994, 5 (3-4) :145-147
[15]   DETERMINATION OF GANGLIOSIDES AND SULFATIDE IN HUMAN CEREBROSPINAL-FLUID WITH A MICROIMMUNOAFFINITY TECHNIQUE [J].
DAVIDSON, P ;
FREDMAN, P ;
MANSSON, JE ;
SVENNERHOLM, L .
CLINICA CHIMICA ACTA, 1991, 197 (02) :105-115
[16]   THE BRAIN IN OLDER PERSONS WITH AND WITHOUT DEMENTIA - FINDINGS ON MR, PET, AND SPECT IMAGES [J].
DAVIS, PC ;
MIRRA, SS ;
ALAZRAKI, N .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (06) :1267-1278
[17]   SULFATIDE AS A BIOCHEMICAL MARKER IN CEREBROSPINAL-FLUID OF PATIENTS WITH VASCULAR DEMENTIA [J].
FREDMAN, P ;
WALLIN, A ;
BLENNOW, K ;
DAVIDSSON, P ;
GOTTFRIES, CG ;
SVENNERHOLM, L .
ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (02) :103-106
[18]  
Godersky J C, 1990, Adv Neurol, V52, P554
[19]  
GOLDSMITH RF, 1987, CLIN CHEM, V33, P1736
[20]   IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS AND SYSTEMIC HYPERTENSION [J].
GRAFFRADFORD, NR ;
GODERSKY, JC .
NEUROLOGY, 1987, 37 (05) :868-871